Neutrophil degranulation mediates severe lung damage triggered by streptococcal M1 protein

European Respiratory Journal

Volumn 32, Issue 2, 2008, Pages 405-412

  Soehnlein, O ^a   Oehmcke, S ^b   Ma, X ^a   Rothfuchs, A G ^c   Frithiof, R ^a   Van Rooijen, N ^d   Morgelin M ^b   Herwald, H ^b   Lindbom, L ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Lung injury; M1 protein; Neutrophil granule proteins; Streptococcus pyogenes

Indexed keywords

BACTERIAL PROTEIN; BETA2 INTEGRIN; FIBRINOGEN; PROTEIN M1; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; CARRIER PROTEIN; OUTER MEMBRANE PROTEIN; STREPTOCOCCAL M PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL COUNT; COMPLEX FORMATION; CONTROLLED STUDY; DEGRANULATION; DISEASE SEVERITY; ELECTRON MICROSCOPY; FEMALE; HISTOPATHOLOGY; LEUKOCYTE COUNT; LUNG INJURY; LUNG LAVAGE; MALE; MOUSE; NEUTROPHIL; NEUTROPHIL GRANULE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BAGG ALBINO MOUSE; HUMAN; LEUKOCYTE ACTIVATION; LUNG; LUNG DISEASE; METABOLISM; MICROBIOLOGY; PERMEABILITY; PHYSIOLOGY; STREPTOCOCCUS PYOGENES;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BRONCHOALVEOLAR LAVAGE FLUID; CARRIER PROTEINS; FEMALE; HUMANS; LUNG; LUNG DISEASES; MALE; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON; NEUTROPHIL ACTIVATION; NEUTROPHILS; PERMEABILITY; STREPTOCOCCUS PYOGENES;

EID: 55849125399     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00173207     Document Type: Article

References (31)

1. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L. Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 2000; 80: 617-653.
2. Moraes TJ, Zurawska JH, Downey GP. Neutrophil granule contents in the pathogenesis of lung injury. Curr Opin Hematol 2006; 13: 21-27.
3. Lee WL, Downey GP. Neutrophil activation and acute lung injury. Curr Opin Crit Care 2001; 7: 1-7.
4. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000; 13: 470-511.
5. Herwald H, Cramer H, Mörgelin M, et al. M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell 2004; 116: 367-379.
6. Gautam N, Olofsson AM, Herwald H, et al. Heparin-binding protein (HBP/CAP37): a missing link in neutrophil-evoked alteration of vascular permeability. Nat Med 2001; 7: 1123-1127.
7. Påhlman LI, Mörgelin M, Eckert J, et al. Streptococcal M protein: a multipotent and powerful inducer of inflammation. J Immunol 2006; 177: 1221-1228.
8. Påhlman LI, Malmström E, Mörgelin M, Herwald H. M protein from Streptococcus pyogenes induces tissue factor expression and pro-coagulant activity in human monocytes. Microbiology 2007; 153: 2458-2464.
9. Eliasson M, Frick IM, Collin M, Sørensen OE, Björck L, Egesten A. M1 protein of Streptococcus pyogenes increases production of the antibacterial CXC chemokine MIG/ CXCL9 in pharyngeal epithelial cells. Microb Pathog 2007; 43: 224-233.
10. Påhlman LI, Olin AI, Darenberg J, et al. Soluble M1 protein of Streptococcus pyogenes triggers potent T cell activation. Cell Microbiol 2008; 10: 404-414.
11. Shannon O, Hertzén E, Norrby-Teglund A, Mörgelin M, Sjöbring U, Björck L. Severe streptococcal infection is associated with M protein-induced platelet activation and thrombus formation. Mol Microbiol 2007; 65: 1147-1157.
12. Conlan JW, North RJ. Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody. J Exp Med 1994; 179: 259-268.
13. Sunderkötter C, Nikolic T, Dillon MJ, et al. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol 2004; 172: 4410-4417.
14. Van Rooijen N, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 1994; 174: 83-93.
15. Soehnlein O, Xie X, Ulbrich H, et al. Neutrophil-derived heparin-binding protein (HBP/CAP37) deposited on endothelium enhances monocyte arrest under flow conditions. J Immunol 2005; 174: 6399-6405.
16. Green TP, Johnson DE, Marchessault RP, Gatto CW. Transvascular flux and tissue accrual of Evans blue: effects of endotoxin and histamine. J Lab Clin Med 1998; 111: 173-183.
17. Suzuki K, Ota H, Sasagawa S, Sakatani T, Fujikura T. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem 1983; 132: 345-352.
18. Schmeisser A, Soehnlein O, Illmer T, et al. ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-κB activity and AT1 receptor expression. Biochem Biophys Res Commun 2004; 325: 532-540.
19. Loike JD, Sodeik B, Cao L, et al. CD11c/CD18 on neutrophils recognizes a domain at the N terminus of the Aα chain of fibrinogen. Proc Natl Acad Sci USA 1991; 88: 1044-1048.
20. Lindbom L. Regulation of vascular permeability by neutrophils in acute inflammation. Chem Immunol Allergy 2003; 83: 146-166.
21. Strieter RM, Kunkel SL. Acute lung injury: the role of cytokines in the elicitation of neutrophils. J Investig Med 1994; 42: 640-651.
22. Sibille Y, Marchandise FX. Pulmonary immune cells in health and disease: polymorphonuclear neutrophils. Eur Respir J 1993; 6: 1529-1543.
23. Soehnlein O, Kenne E, Rotzius P, Eriksson EE, Lindbom L. Neutrophil secretion products regulate antimicrobial activity in monocytes and macrophages. Clin Exp Immunol 2008; 151: 139-145.
24. Borregaard N, Sørensen OE, Theilgaard-Mönch K. Neutrophil granules: a library of innate immunity proteins. Trends Immunol 2007; 28: 340-345.
25. Theilgaard-Mönch K, Jacobsen LC, Borup R, et al. The transcriptional program of terminal granulocytic differentiation. Blood 2005; 105: 1785-1796.
26. Suzuki T, Moraes TJ, Vachon E, et al. Proteinase-activated receptor-1 mediates elastase-induced apoptosis of human lung epithelial cells. Am J Respir Cell Mol Biol 2005; 33: 231-247.
27. Stefansson S, Yepes M, Gorlatova N, et al. Mutants of plasminogen activator inhibitor-1 designed to inhibit neutrophil elastase and cathepsin G are more effective in vivo than their endogenous inhibitors. J Biol Chem 2004; 279: 29981-29987.
28. Ulbrich H, Eriksson EE, Lindbom L. Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease. Trends Pharmacol Sci 2003; 24: 640-647.
29. Chertov O, Yang D, Howard OM, Oppenheim JJ. Leukocyte granule proteins mobilize innate host defenses and adaptive immune responses. Immunol Rev 2000; 177: 68-78.
30. Takashi S, Park J, Fang S, Koyama S, Parikh I, Adler KB. A peptide against the N-terminus of myristoylated alanine-rich C kinase substrate inhibits degranulation of human leukocytes in vitro. Am J Respir Cell Mol Biol 2006; 34: 647-652.
31. Singer M, Martin LD, Vargaftig BB, et al. A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma. Nat Med 2004; 10: 193-196.